what are the Recommendations for Statin Therapy Use in Patients With ASCVD
Referenced studies that support recommendations are summarized
in Online Data Supplements 6 to 8 and in the Systematic Review
Report.?
In patients with clinical ASCVD who are judged to be very high risk and considered for PCSK9 inhibitor therapy, maximally tolerated LDL-C lowering therapy should include maximally tolerated statin therapy and ezetimibe.S